Related references
Note: Only part of the references are listed.Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation
Jing Zhao et al.
PLOS BIOLOGY (2018)
MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1 (Publication with Expression of Concern. See vol. 330, pg. 125, 2021)
Yun-Cheng Lv et al.
ATHEROSCLEROSIS (2014)
miR33 Inhibition Overcomes Deleterious Effects of Diabetes Mellitus on Atherosclerosis Plaque Regression in Mice
Emilie Distel et al.
CIRCULATION RESEARCH (2014)
Systemic Delivery of MicroRNA-181b Inhibits Nuclear Factor-κB Activation, Vascular Inflammation, and Atherosclerosis in Apolipoprotein E-Deficient Mice
Xinghui Sun et al.
CIRCULATION RESEARCH (2014)
Inhibition of MicroRNA-92a Prevents Endothelial Dysfunction and Atherosclerosis in Mice
Xavier Loyer et al.
CIRCULATION RESEARCH (2014)
The Roles of MicroRNAs in Atherosclerosis
Xinjie Lu et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Noncoding RNAs in vascular disease
Amy Leung et al.
CURRENT OPINION IN CARDIOLOGY (2014)
Noncoding RNAs in vascular inflammation and atherosclerosis: recent advances toward therapeutic applications
Clement Cochain et al.
CURRENT OPINION IN LIPIDOLOGY (2014)
ClC-3 chloride channel/antiporter defect contributes to inflammatory bowel disease in humans and mice
Lin-Yan Huang et al.
GUT (2014)
MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1
Andreas Schober et al.
NATURE MEDICINE (2014)
An Agomir of miR-144-3p Accelerates Plaque Formation through Impairing Reverse Cholesterol Transport and Promoting Pro-Inflammatory Cytokine Production
Yan-Wei Hu et al.
PLOS ONE (2014)
Therapeutic Silencing of MicroRNA-33 Inhibits the Progression of Atherosclerosis in Ldlr-/- MiceBrief Report
Noemi Rotllan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
The microRNA-342-5p Fosters Inflammatory Macrophage Activation Through an Akt1-and microRNA-155-Dependent Pathway During Atherosclerosis
Yuanyuan Wei et al.
CIRCULATION (2013)
MicroRNAs and Atherosclerosis
Julio Madrigal-Matute et al.
CURRENT ATHEROSCLEROSIS REPORTS (2013)
Endothelial MicroRNAs and Atherosclerosis
Xinghui Sun et al.
CURRENT ATHEROSCLEROSIS REPORTS (2013)
Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans
Peter Libby et al.
IMMUNITY (2013)
Adaptive immunity in atherogenesis: new insights and therapeutic approaches
Andrew H. Lichtman et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment
Daniel Quiat et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion
James Soh et al.
NATURE MEDICINE (2013)
miR-181a Regulates Inflammation Responses in Monocytes and Macrophages
Weidong Xie et al.
PLOS ONE (2013)
Critical role for miR-181a/b-1 in agonist selection of invariant natural killer T cells
Natalia Zietara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
NEMO differentially regulates TCR and TNF-α induced NF-κB pathways and has an inhibitory role in TCR-induced NF-κB activation
Kai Wang et al.
CELLULAR SIGNALLING (2012)
Downregulation of TMEM16A Calcium-Activated Chloride Channel Contributes to Cerebrovascular Remodeling During Hypertension by Promoting Basilar Smooth Muscle Cell Proliferation
Mi Wang et al.
CIRCULATION (2012)
MicroRNA-145 Targeted Therapy Reduces Atherosclerosis
Fina Lovren et al.
CIRCULATION (2012)
The Role of microRNAs in Cardiovascular Disease
N. Papageorgiou et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Decrease of Intracellular Chloride Concentration Promotes Endothelial Cell Inflammation by Activating Nuclear Factor-κB Pathway
Hui Yang et al.
HYPERTENSION (2012)
Decreased miR-181a Expression in Monocytes of Obese Patients Is Associated with the Occurrence of Metabolic Syndrome and Coronary Artery Disease
Maarten Hulsmans et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages
Maliheh Nazari-Jahantigh et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
microRNA-181a represses ox-LDL-stimulated inflammatory response in dendritic cell by targeting c-Fos
Chaoneng Wu et al.
JOURNAL OF LIPID RESEARCH (2012)
Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity
Guangjin Li et al.
NATURE MEDICINE (2012)
The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α
Shu Zhu et al.
NATURE MEDICINE (2012)
MicroRNA-33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE-/- Mice
Takahiro Horie et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2012)
Immune Modulation of Atherosclerosis
John F. Keaney
CIRCULATION (2011)
Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a
Wei Wu et al.
CIRCULATION (2011)
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis
Katey J. Rayner et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
Katey J. Rayner et al.
NATURE (2011)
Simvastatin Ameliorates Rat Cerebrovascular Remodeling During Hypertension via Inhibition of Volume-Regulated Chloride Channel
Yu-Jie Liu et al.
HYPERTENSION (2010)
MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis
S. Hani Najafi-Shoushtari et al.
SCIENCE (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Inflammation in Atherosclerosis From Pathophysiology to Practice
Peter Libby et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
NUMBL interacts with TAB2 and inhibits TNFα and IL-1β-induced NF-κB activation
Qi Ma et al.
CELLULAR SIGNALLING (2008)
miR-181a is an intrinsic modulator of T cell sensitivity and selection
Qi-Jing Li et al.
CELL (2007)
Share Paper
